Solara Active Pharma Sciences Ltd. - Research Center
541540 SOLARA Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 36.00 | 35.92 | 26.85 | 25.77 | 24.67 |
| Share application money | - | - | 96.00 | 104.00 | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 1,491.05 | 1,556.86 | 967.94 | 835.96 | 745.19 |
| Loan funds | |||||
| Secured loans | 1,024.57 | 515.71 | 586.50 | 439.43 | 573.08 |
| Unsecured loans | - | - | - | - | - |
| Total | 2,551.62 | 2,108.49 | 1,677.29 | 1,405.16 | 1,342.94 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 1,683.07 | 1,625.90 | 1,549.36 | 1,189.27 | 1,088.69 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 348.92 | 266.89 | 175.27 | 89.65 | 26.15 |
| Net block | 1,334.15 | 1,359.01 | 1,374.09 | 1,099.62 | 1,062.54 |
| Capital work-in-progress | 238.65 | 87.72 | 40.21 | 33.65 | 70.31 |
| Investments | 18.13 | 18.13 | 18.03 | 149.13 | 18.53 |
| Net current assets | |||||
| Current assets, loans & advances | 1,358.74 | 1,145.31 | 719.28 | 652.41 | 665.79 |
| Less : current liabilities & provisions | 398.05 | 501.68 | 474.32 | 529.65 | 474.23 |
| Total net current assets | 960.69 | 643.63 | 244.96 | 122.76 | 191.57 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 2,551.62 | 2,108.49 | 1,677.29 | 1,405.16 | 1,342.94 |
| Notes: | |||||
| Book value of unquoted investments | 17.71 | 18.13 | 18.03 | 149.13 | 18.53 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 66.88 | 104.50 | 73.51 | 95.73 | - |
| Number of equity sharesoutstanding (Lacs) | 359.96 | 359.30 | 268.55 | 257.74 | 246.74 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis